American Marconi Wireless News

NYSE - LSE

CMSD	0%	22.29	$
CMSC	0.22%	22.37	$
GSK	-2.92%	50.67	$
BTI	-0.98%	58.91	$
RIO	-2.59%	100.08	$
AZN	-1.69%	174.93	$
BCE	0%	23.28	$
BCC	5.16%	74.66	$
NGG	-1.56%	79.44	$
JRI	0.39%	12.67	$
RBGPF	-0.87%	60.61	$
RYCEF	-0.16%	18.4	$
RELX	-2.66%	31.18	$
BP	-2.66%	39.1	$
VOD	-1.61%	14.3	$

Featured

Rare Philippine school shooting kills three teens, wounds seven

Two students opened fire Monday inside a school in the central Philippines, a rare campus shooting that killed three teens and wounded seven others, police said.

Kenya labour minister accused over Russian forced recruitment

Erastus Mundia left Kenya on a work programme his government had arranged with Russia. He died on the battlefield in Ukraine, and his family holds Labour Minister Alfred Mutua responsible.

Last news

IDLife Strengthens Scientific Leadership with Appointment of Dr. Michael Hartman, PhD, as Chair of Scientific & Medical Advisory Board

Appointment Signals Continued Expansion of IDLife's Science, Product Innovation, and Personalized Nutrition Platform

EHDS Readiness Shifts from EU Policy to Provider Budget and Vendor Accountability

Black Book Research's Pre-HIMSS26 Europe study of 881 healthcare leaders across 14 countries finds European Health Data Space readiness is now a provider funding, vendor accountability, and data execution challenge

NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering

SHELTON, CT / ACCESS Newswire / May 15, 2026 / NanoViricides, Inc. (NYSE American:NNVC) ("NanoViricides" or the "Company"), a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses and their variants cannot escape, today announced it has entered into a securities purchase agreement with a single fundamental institutional investor for the purchase and sale of 1,333,334 million common shares (or pre-funded warrants in lieu thereof), together with accompanying warrants to purchase 1,333,334 common shares for gross proceeds of approximately US$2 million in a registered direct offering (the "Offering"). The common shares are being sold in combination with an accompanying full warrant (with each whole warrant being exercisable into one common share of the Company). Each whole warrant has an exercise price of US$1.75 per share and will expire three years from the date of issuance.

NanoViricides, Inc. Has Filed its Quarterly Report - NV-387 Advancing for Phase II

SHELTON, CT / ACCESS Newswire / May 15, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ending March 31, 2026 with the Securities and Exchange Commission (SEC) on Thursday, May 14, 2026. The report can be accessed at the SEC website by searching for the Company (https://www.sec.gov/edgar/browse/?CIK=1379006&owner=exclude) .

InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 15

InterContinental Hotels Group PLC (the "Company")Purchase of own shares

Afghanistan's water crisis worsened last year: UN report

Afghanistan's water crisis worsened in 2025, the United Nations said in a report, with drought nearly doubling compared to the year before.

US jury awards $49.5 mn damages to Boeing 737 MAX victim's family

A US jury awarded $49.5 million in damages on Wednesday to the family of a 24-year-old American who perished in a 2019 Boeing 737 MAX crash.

South Africa court clears way for Zuma's arms graft trial

A South African court ruled Thursday that a long-running arms deal corruption case against former president Jacob Zuma and French defence giant Thales can proceed, rejecting bids to delay the trial.

Ex-Philippine drug war enforcer flees Senate refuge

The chief enforcer of former Philippine president Rodrigo Duterte's deadly drug war has fled the Senate, where he had sought refuge this week to escape arrest for crimes against humanity, the chamber's president said on Thursday.

Japan takes 'half step' toward fixing slow retrial system

Japanese policymakers have approved a proposal to reduce the power of prosecutors to thwart a process for exonerating potential victims of wrongful convictions, following an outcry over the country's retrial system.

Six hantavirus cruise passengers head to Australia

Six passengers who sailed on a hantavirus-affected cruise will fly to Australia from the Netherlands on Thursday while dressed in full protective gear, the Australian government said.

US court suspends sanctions on UN expert on Palestinians

A US judge on Wednesday imposed a temporary injunction on sanctions imposed last year by Washington on a United Nations expert on the occupied Palestinian territories.

Ethical Artform of Perfumery Remixes Displayed in NYC, Berlin and London

Naked Ghosts, an art gallery and store in Manhattan's West Village, is pleased to introduce two scent sculptures, Augmented Reality and F*** The Fluff.

374Water Reports First Quarter 2026 Financial Results; Gross Margins Expands Year-Over-Year as Company Advances Contracted Deployments, Waste Destruction Services Platform, and Strategic Partnerships

Recurring Revenue Platform Takes Shape as Contracted Operations Scale Across Municipal, Federal, and Industrial Markets

Stolon Introduces the Restaurant Industry's First Hand Cut Seed Oil Free Fry Platform

Crafted for Performance Chefs. Loved by Demanding Guests.

Newsmax Announces First Quarter 2026 Financial Results

Company Reports Quarterly Revenues of $51.7 million, a 14.0% Year-Over-Year IncreaseBroadcast Revenues Increase to $43.7 million, a 20.8% Increase Year-Over-YearCompany Reaffirms Full-Year 2026 Revenue Guidance, Representing Accelerated Year-Over-Year Growth of 13% at the Midpoint

CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results

SAN DIEGO, CA / ACCESS Newswire / May 14, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended March 31, 2026.

Wellgistics Health Accelerates Digital Health Expansion of its Newly Announced RPM, RTM and CCM Pilot with Planned Acquisition of WellCare Today and its Proprietary Samsung Galaxy Watch Care Monitoring Program

Highlights:WellCare Today brings established RPM, RTM and CCM infrastructure with wearable technology integrations and connected monitoring solutionsCombination expected to integrate Wellgistics Health recently announced MSO initiative with Kare Clinicals and its network of 6,500+ independent pharmaciesProposed platform designed to enhance patient engagement, medication adherence, remote monitoring and longitudinal care coordinationProposed transaction valued at approximately $15 millionStrategic initiative intended to create additional clinical revenue opportunities for participating pharmacies and providers

CMS Hemp Program Insiders Admit Bypassing FDA Safety Standards for a Potential $34.5 Billion Medicare Payday

BEI Participants Publicly Discuss "Bypassing" FDA Pathway as Federal Court Weighs Legality of CMS Cannabinoid ProgramOn-Camera Statements From CMS Cannabinoid Program Participants Raise New Questions About Scientific Standards, Commercialization and Federal Authority

ALYZE Prepares to Open Utah's First Facility Where Your Gym, Doctor, Lab, and Recovery are All Under One Roof

The Bountiful flagship brings together comprehensive diagnostics, functional medicine, luxury fitness, and full recovery services into one coordinated membership, giving Utah professionals access to a level of integrated health care that has never existed in the consumer market

Hippocratic Cancer Research Foundation Announces Two Signature Chicago Fundraising Events: "Sail and Soiree" Fashion Show and "Golden Hour for Good" Rooftop Party

HCRF will bring together Chicago's philanthropic, medical, civic, and business communities for two June 2026 events supporting innovative cancer research at Northwestern University's Robert H. Lurie Comprehensive Cancer Center.

Pearl Planner by David's Bridal Expands Agentic AI Features with New Free Budgeting Engine, Removing Financial Guesswork out of Wedding Planning

World's Leading AI-Powered Wedding Planning Platform, Pearl Planner by David's, Newest Feature Turns Budgeting into Actionable Clarity Through Dynamic AI

Trustpoint Xposure Establishes Itself as the Definitive Authority on AEO, The Discipline Reshaping How Brands Are Found, Trusted, and Recommended by AI

As AI platforms replace traditional search for high-value professional discovery, Trustpoint Xposure leads the industry in helping brands become the single answer ChatGPT, Gemini, Claude, and Perplexity recommend

The Data-Ready Hospital: Europe's EHR Vendors Face the Data Valorisation Reality Check

Black Book Research survey of 662 healthcare IT leaders across eight European EMR markets finds post-go-live data-value execution separates top-performing vendors from vendors that sell data transformation better than they deliver it in 2026

Desert Oasis Healthcare's "The Pulse" TV Show Wins Platinum Viddy Award for Alzheimer's Episode

DOHC's original television and digital series, The Pulse, earns its second Viddy Award for excellence in healthcare storytelling and community impact

Fast Finance Pay Corp Announces First Quarter 2026 Financial Results

NEW YORK, NY / ACCESS Newswire / May 14, 2026 / Fast Finance Pay Corp. (OTC PINK:FFPP) today announced its financial results for the first quarter ended March 31, 2026.

Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt Program

Advisory Agreement Secured: To advance the Company's EIB-backed R&D financing program€25 million potential financing opportunity: Up to 50% of the Company's €50 million planned R&D programInstitutional-grade capital: Potential long-term, attractively structured financing from the EU's premier development bankR&D acceleration: Strengthens and expands the Company's development pipeline across its portfolioValue creation catalyst: Landmark funding opportunity supporting long-term innovation and growth

NCQA Receives Grant from the Helmsley Charitable Trust to Advance High-Quality Diabetes Care

The project will develop new diabetes quality measures, elevate digital tools and strengthen accountability for improved patient outcomes.

Dr. Anurag Agarwal Shares Insights on Improving Outcomes with Revision Facelift Surgery

Naples facial plastic surgeon highlights the importance of individualized surgical planning and technique in revision facelift cases

Moolec Science Successfully Completes 2026 GLASO Commercial Planting Campaign in the United States

WARWICK, GB / ACCESS Newswire / May 14, 2026 / Moolec Science Limited, a wholly owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced the successful completion of the 2026 commercial planting campaign for its GLASO1 safflower program focused on the production of high-GLA ("Gamma-Linolenic Acid") specialty oils for industrial and advanced ingredient applications.

MIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Data for Ketamir-2

Selective oral NMDA receptor modulator demonstrated favorable safety, tolerability, and pharmacokinetic profile supporting planned Phase 2a development in chemotherapy-induced peripheral neuropathy

CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress

Oversubscribed $22.5 million financing anticipated to enable CNS Pharmaceuticals to acquire differentiated, clinical-stage assets with identifiable near-term value-inflection catalysts, aligned with its recently announced corporate strategyCompany actively evaluating multiple acquisition opportunities while advancing discussions to out-license its legacy glioblastoma multiforme programs, Berubicin and TPI-287New executive leadership team assembled in the first quarter continues to demonstrate rapid execution against strategy

American Marconi Wireless News - Boulevard (English)